Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$670,051,957
-$731,616,305 QoQ
Shares Held
27,826,078
-44.3% QoQ
Ownership
0.488%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#24
of 2,816 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $41,461,553,100 across 12 Drug Manufacturers - General names. PFE ranks #9 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,998,953 | $13,192,475,293 | |
| 2 | MRK |
Merck & Co., Inc.
|
86,249,283 | $11,083,032,864 | |
| 3 | JNJ |
Johnson & Johnson
|
22,588,696 | $5,736,851,118 | |
| 4 | AZN |
Astrazeneca PLC
|
28,537,243 | $5,411,232,013 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,699,683 | $1,604,477,945 | |
| 6 | ABBV |
AbbVie Inc.
|
5,055,589 | $1,272,188,413 | |
| 7 | AMGN |
Amgen Inc
|
2,742,271 | $993,031,171 | |
| 8 | BIIB |
Biogen Inc.
|
3,117,469 | $673,560,350 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $670,051,957 | 27,826,078 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,401,668,262 | 49,916,961 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,297,148,316 | 52,094,310 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,540,570,558 | 60,461,953 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,866,565,781 | 77,003,539 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,622,530,328 | 103,493,699 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,713,958,281 | 139,990,889 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $4,738,268,636 | 163,727,320 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,653,629,707 | 166,319,861 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,931,108,952 | 177,697,620 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,886,849,215 | 239,209,768 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $7,566,433,374 | 228,110,744 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $8,550,476,264 | 233,110,040 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $8,932,422,863 | 218,931,933 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $10,213,647,366 | 199,329,574 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $9,227,852,888 | 210,874,152 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,491,169,448 | 219,171,647 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $11,217,228,557 | 216,674,301 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $13,074,832,100 | 221,419,680 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $9,503,006,678 | 220,948,772 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,465,803,676 | 241,721,238 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $9,049,550,518 | 249,780,583 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $9,073,369,559 | 246,491,974 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $8,615,094,720 | 234,743,957 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $8,202,952,881 | 250,854,569 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,137,579,702 | 218,676,145 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||